Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Ashwani Verma is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.30 | 33.28% | Ashwani Verma48% | $145 → $179 | Upgrade | Neutral → Buy | Get Alert |
| 03/04/2025 | ALKS | Buy Now | Alkermes | $34.69 | — | Ashwani Verma48% | — | Upgrade | Sell → Neutral | Get Alert |
| 01/30/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | 71.97% | Ashwani Verma48% | $30 → $27 | Maintains | Buy | Get Alert |
| 01/30/2025 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | 52.82% | Ashwani Verma48% | $162 → $176 | Maintains | Buy | Get Alert |
| 01/28/2025 | EXEL | Buy Now | Exelixis | $37.44 | -9.19% | Ashwani Verma48% | $30 → $34 | Maintains | Neutral | Get Alert |
| 01/23/2025 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | 91.08% | Ashwani Verma48% | $28 → $30 | Maintains | Buy | Get Alert |
| 01/13/2025 | AVDL | Buy Now | Avadel Pharmaceuticals | $8.53 | 64.13% | Ashwani Verma48% | $22 → $14 | Maintains | Buy | Get Alert |
| 01/08/2025 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | 40.66% | Ashwani Verma48% | $142 → $162 | Maintains | Buy | Get Alert |
| 01/08/2025 | UTHR | Buy Now | United Therapeutics | $321.00 | 47.98% | Ashwani Verma48% | $415 → $475 | Maintains | Buy | Get Alert |
| 12/10/2024 | ACLX | Buy Now | Arcellx | $71.37 | 59.73% | Ashwani Verma48% | $106 → $114 | Maintains | Buy | Get Alert |
| 09/19/2024 | EXEL | Buy Now | Exelixis | $37.44 | -19.87% | Ashwani Verma48% | → $30 | Initiates | → Neutral | Get Alert |
| 09/10/2024 | HRMY | Buy Now | Harmony Biosciences | $33.82 | 65.58% | Ashwani Verma48% | → $56 | Initiates | → Buy | Get Alert |
| 09/03/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | 65.61% | Ashwani Verma48% | $24 → $26 | Maintains | Buy | Get Alert |
| 08/16/2024 | CHRS | Buy Now | Coherus BioSciences | $0.97 | 55.3% | Ashwani Verma48% | $4 → $1.5 | Downgrade | Buy → Neutral | Get Alert |
| 08/13/2024 | BHVN | Buy Now | Biohaven | $30.40 | 77.63% | Ashwani Verma48% | $55 → $54 | Maintains | Buy | Get Alert |
| 08/08/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -40.02% | Ashwani Verma48% | $83 → $79 | Maintains | Neutral | Get Alert |
| 08/08/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 34.98% | Ashwani Verma48% | $25 → $23 | Maintains | Buy | Get Alert |
| 08/06/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.42 | -13.52% | Ashwani Verma48% | $107 → $105 | Maintains | Buy | Get Alert |
| 07/10/2024 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | 52.87% | Ashwani Verma48% | $22 → $24 | Maintains | Buy | Get Alert |
| 07/08/2024 | UTHR | Buy Now | United Therapeutics | $321.00 | 15.26% | Ashwani Verma48% | $300 → $370 | Maintains | Buy | Get Alert |
| 07/02/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.30 | -15.86% | Ashwani Verma48% | $117 → $113 | Maintains | Neutral | Get Alert |
| 06/25/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -36.98% | Ashwani Verma48% | $85 → $83 | Downgrade | Buy → Neutral | Get Alert |
| 06/03/2024 | RPRX | Buy Now | Royalty Pharma | $33.62 | -16.72% | Ashwani Verma48% | → $28 | Downgrade | Buy → Neutral | Get Alert |
| 05/28/2024 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | 67.58% | Ashwani Verma48% | $174 → $193 | Maintains | Buy | Get Alert |
| 04/30/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 58.45% | Ashwani Verma48% | $33 → $27 | Maintains | Buy | Get Alert |
| 04/23/2024 | BHVN | Buy Now | Biohaven | $30.40 | 97.37% | Ashwani Verma48% | $59 → $60 | Maintains | Buy | Get Alert |
| 03/18/2024 | LEGN | Buy Now | Legend Biotech | $36.00 | 125% | Ashwani Verma48% | $76 → $81 | Maintains | Buy | Get Alert |
| 03/01/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.30 | -2.46% | Ashwani Verma48% | $135 → $131 | Maintains | Neutral | Get Alert |
| 02/20/2024 | ALKS | Buy Now | Alkermes | $34.69 | -27.93% | Ashwani Verma48% | $25 → $25 | Downgrade | Neutral → Sell | Get Alert |
| 02/06/2024 | AXSM | Buy Now | Axsome Therapeutics | $121.42 | -8.58% | Ashwani Verma48% | → $111 | Initiates | → Buy | Get Alert |
| 02/06/2024 | BHVN | Buy Now | Biohaven | $30.40 | 94.08% | Ashwani Verma48% | → $59 | Initiates | → Buy | Get Alert |
| 02/06/2024 | AVDL | Buy Now | Avadel Pharmaceuticals | $8.53 | 146.19% | Ashwani Verma48% | → $21 | Initiates | → Buy | Get Alert |
| 01/24/2024 | CYTK | Buy Now | Cytokinetics | $44.01 | 109.04% | Ashwani Verma48% | $61 → $92 | Downgrade | Buy → Neutral | Get Alert |
| 01/02/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -37.74% | Ashwani Verma48% | $74 → $82 | Maintains | Buy | Get Alert |
| 11/27/2023 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.30 | 0.52% | Ashwani Verma48% | $170 → $135 | Downgrade | Buy → Neutral | Get Alert |
| 11/27/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | -17.2% | Ashwani Verma48% | $11 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 10/17/2023 | ALKS | Buy Now | Alkermes | $34.69 | -10.64% | Ashwani Verma48% | → $31 | Initiates | → Neutral | Get Alert |
| 10/17/2023 | ACLX | Buy Now | Arcellx | $71.37 | -27.14% | Ashwani Verma48% | → $52 | Initiates | → Buy | Get Alert |
| 10/17/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.04 | 93.66% | Ashwani Verma48% | → $33 | Initiates | → Buy | Get Alert |
| 09/20/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | -29.94% | Ashwani Verma48% | $8 → $11 | Maintains | Neutral | Get Alert |
| 08/07/2023 | CHRS | Buy Now | Coherus BioSciences | $0.97 | 624.71% | Ashwani Verma48% | $11 → $7 | Maintains | Buy | Get Alert |
| 08/07/2023 | COHR | Buy Now | Coherent | $74.73 | -90.63% | Ashwani Verma48% | $11 → $7 | Maintains | Buy | Get Alert |
| 07/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | -0.15% | Ashwani Verma48% | $121 → $115 | Maintains | Buy | Get Alert |
| 07/06/2023 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | -49.04% | Ashwani Verma48% | $7 → $8 | Upgrade | Sell → Neutral | Get Alert |
| 04/10/2023 | UTHR | Buy Now | United Therapeutics | $321.00 | -3.43% | Ashwani Verma48% | $330 → $310 | Maintains | Buy | Get Alert |
| 04/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | 8.54% | Ashwani Verma48% | $137 → $125 | Maintains | Buy | Get Alert |
| 04/03/2023 | CYTK | Buy Now | Cytokinetics | $44.01 | 38.6% | Ashwani Verma48% | $67 → $61 | Maintains | Buy | Get Alert |
| 03/29/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -52.16% | Ashwani Verma48% | $62 → $63 | Maintains | Buy | Get Alert |
| 03/28/2023 | CHRS | Buy Now | Coherus BioSciences | $0.97 | 1038.83% | Ashwani Verma48% | → $11 | Upgrade | Neutral → Buy | Get Alert |
| 02/16/2023 | RPRX | Buy Now | Royalty Pharma | $33.62 | 42.77% | Ashwani Verma48% | $51 → $48 | Maintains | Buy | Get Alert |
| 01/27/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | Ashwani Verma48% | → $209 | Initiates | → Neutral | Get Alert |
| 12/15/2022 | CYTK | Buy Now | Cytokinetics | $44.01 | 49.97% | Ashwani Verma48% | $80 → $66 | Maintains | Neutral | Get Alert |
| 12/06/2022 | LEGN | Buy Now | Legend Biotech | $36.00 | 83.33% | Ashwani Verma48% | → $66 | Initiates | → Buy | Get Alert |
| 12/06/2022 | UTHR | Buy Now | United Therapeutics | $321.00 | -0.31% | Ashwani Verma48% | → $320 | Initiates | → Buy | Get Alert |
| 11/10/2022 | VTRS | Buy Now | Viatris | $8.96 | 33.95% | Ashwani Verma48% | $9 → $12 | Upgrade | Sell → Neutral | Get Alert |
| 10/11/2022 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.47 | 920.41% | Ashwani Verma48% | → $15 | Initiates | → Buy | Get Alert |
| 10/11/2022 | NBIX | Buy Now | Neurocrine Biosciences | $115.17 | 18.09% | Ashwani Verma48% | → $136 | Initiates | → Buy | Get Alert |
| 10/11/2022 | CYTK | Buy Now | Cytokinetics | $44.01 | 81.78% | Ashwani Verma48% | → $80 | Initiates | → Buy | Get Alert |
| 08/04/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.30 | 42.22% | Ashwani Verma48% | $194 → $191 | Maintains | Buy | Get Alert |
| 08/04/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | Ashwani Verma48% | $137 → $71 | Downgrade | Buy → Neutral | Get Alert |
| 07/05/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | Ashwani Verma48% | $139 → $137 | Maintains | Buy | Get Alert |
| 06/14/2022 | VTRS | Buy Now | Viatris | $8.96 | 0.46% | Ashwani Verma48% | → $9 | Initiates | → Sell | Get Alert |
| 06/14/2022 | RPRX | Buy Now | Royalty Pharma | $33.62 | 39.8% | Ashwani Verma48% | → $47 | Initiates | → Buy | Get Alert |
| 06/14/2022 | TEVA | Buy Now | Teva Pharmaceutical Indus | $15.70 | -36.31% | Ashwani Verma48% | → $10 | Initiates | → Neutral | Get Alert |
| 06/14/2022 | CHRS | Buy Now | Coherus BioSciences | $0.97 | 624.71% | Ashwani Verma48% | → $7 | Initiates | → Neutral | Get Alert |
| 06/14/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $131.70 | -43.05% | Ashwani Verma48% | → $75 | Initiates | → Buy | Get Alert |
| 06/14/2022 | JAZZ | Buy Now | Jazz Pharmaceuticals | $134.30 | 44.45% | Ashwani Verma48% | → $194 | Initiates | → Buy | Get Alert |
| 06/14/2022 | HZNP | Buy Now | Horizon Therapeutics | — | — | Ashwani Verma48% | → $139 | Initiates | → Buy | Get Alert |
| 06/14/2022 | DHT.UN | Buy Now | DRI Healthcare Trust | — | — | Ashwani Verma48% | → $10 | Initiates | → Buy | Get Alert |
| 03/22/2021 | KRTX | Buy Now | Karuna Therapeutics | — | — | Ashwani Verma48% | → $150 | Initiates | → Buy | Get Alert |
